Page last updated: 2024-10-21

urea and Lymphoma, Mantle-Cell

urea has been researched along with Lymphoma, Mantle-Cell in 2 studies

pseudourea: clinical use; structure
isourea : A carboximidic acid that is the imidic acid tautomer of urea, H2NC(=NH)OH, and its hydrocarbyl derivatives.

Lymphoma, Mantle-Cell: A form of non-Hodgkin lymphoma having a usually diffuse pattern with both small and medium lymphocytes and small cleaved cells. It accounts for about 5% of adult non-Hodgkin lymphomas in the United States and Europe. The majority of mantle-cell lymphomas are associated with a t(11;14) translocation resulting in overexpression of the CYCLIN D1 gene (GENES, BCL-1).

Research Excerpts

ExcerptRelevanceReference
"Dasatinib treatment partly restored PF-00477736 sensitivity in resistant cells suggesting that the pharmacological interference of pro-survival pathways can overcome the resistance to Chk1 inhibitors."1.42Characterization of a mantle cell lymphoma cell line resistant to the Chk1 inhibitor PF-00477736. ( Bertoni, F; Carrassa, L; ChilĂ , R; Damia, G; Kwee, I; Lupi, M; Restelli, V; Rinaldi, A, 2015)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Restelli, V1
ChilĂ , R1
Lupi, M1
Rinaldi, A1
Kwee, I1
Bertoni, F1
Damia, G1
Carrassa, L1
Qi, W1
Liu, X1
Cooke, LS1
Persky, DO1
Miller, TP1
Squires, M1
Mahadevan, D1

Other Studies

2 other studies available for urea and Lymphoma, Mantle-Cell

ArticleYear
Characterization of a mantle cell lymphoma cell line resistant to the Chk1 inhibitor PF-00477736.
    Oncotarget, 2015, Nov-10, Volume: 6, Issue:35

    Topics: Antineoplastic Agents; Benzodiazepinones; Cell Cycle; Cell Cycle Proteins; Cell Line, Tumor; Cell Pr

2015
AT9283, a novel aurora kinase inhibitor, suppresses tumor growth in aggressive B-cell lymphomas.
    International journal of cancer, 2012, Jun-15, Volume: 130, Issue:12

    Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Aurora Ki

2012